Back to Search
Start Over
AIVITA Biomedical completes treatment of patients in phase 2 trial of AV-GBM-1 to treat glioblastoma
- Source :
- PharmaBiz. November 4, 2020
- Publication Year :
- 2020
-
Abstract
- AIVITA Biomedical, a private biotechnology company, announced that treatment has been completed for all 57 patients in the phase 2 clinical trial of AV-GBM-1 in patients with glioblastoma. The company [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.640629688